Cardiac Drug Stent Market Growth Prospects, Trends, Segments, Key Players and Forecast to 2032
The global size for Cardiac Drug Stents Market reached USD 9.93 billion in 2022, with expectations of registering a revenue compound annual growth rate (CAGR) of 5.9% during the forecast period. Key drivers propelling market revenue growth include the increasing prevalence of cardiovascular diseases, a shift in preference toward minimally invasive therapeutic procedures, the expedited evaluation and approval of cardiac drug stents, and the integration of technological innovations in stent mechanisms.
